PROVEO™ provides complete and efficient solutions for antibody drug conjugates (ADCs)
Proveo leverages AGC Biologics' specialized expertise in monoclonal antibody production, with Cerbios' proficiency in bioconjugation and cytotoxic drug-linker payload, while Oncotec provides aseptic fill and lyophilization of the ADC drug product, supply chain, and secondary packaging through to ready-to-deliver final drug product.
Your All-in-One ADC Solution
- Combined strength and expertise of three industry leaders into one integrated solution.
- World-class cGMP commercial manufacturing facilities with presence in three continents
- FDA, EMA, Swissmedic and PMDA approved with an exceptional regulatory track record
- Successful development of 200+ biologics
- DS and DP contract manufacturing for more than 20 companies
- Leaders in implementation of innovative technologies and solutions that accelerate time to market
- Extensive experience in regulatory support for IND and NDA
Providing full development and manufacturing of ADCs
Risk-free timeline compression from DNA to fill & finish
mAb developer & manufacturing
With 25+ years of experience in recombinant protein manufacturing, AGC Biologics provides process development, clinical supply, and commercial cGMP manufacturing and is approved for commercial production by the FDA, EMA, HC, PMDA, and ANVISA.
Copenhagen Facility
HPAPI payloads & conjugation
Cerbios-Pharma SA provides 25+ years of experience in high-potency APIs and conjugation. Located in Lugano, Switzerland, Cerbios provides full CMC support to its world-wide partners, including the supply of cGMP clinical batches, registration/validation material and commercially manufactured APIs.
Aseptic fill & finish with lyophilization
Oncotec Pharma Produktion GmbH is a reliable partner in the production and development of aseptically produced cytostatic world and brings 25+ years of experience with small and large scale filling line with lyophilization and vial washing for high potent drug ADC.
